University of Alberta
Betty Wang, M.D., is a urologic oncology fellow at the Cleveland Clinic. She previously trained at the University of Alberta in Canada, where she completed her medical school and urology residency. Her current research focuses on the role of advanced biomarkers, including circulating tumor DNA, in various stages of bladder cancer, as well as the integration of artificial intelligence in urologic oncology. She is particularly interested in how these emerging technologies can enhance cancer detection, prognostication, and treatment strategies.
Disclosure information not submitted.